Concepedia

Publication | Open Access

Attenuated FOLFIRINOX in the salvage treatment of gemcitabine‐refractory advanced pancreatic cancer: a phase II study

28

Citations

22

References

2018

Year

Abstract

Attenuated FOLFIRINOX may be promising as a second-line therapy for gemcitabine-refractory pancreatic cancer.

References

YearCitations

Page 1